A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease

Epigenomics. 2015;7(1):17-34. doi: 10.2217/epi.14.64.

Abstract

Aim: To assess whether DNA methylation is associated with coronary artery disease (CAD).

Materials & methods: An epigenome-wide analysis has been performed on leucocytes from familial hypercholesterolemic (FH) men with (n = 6) or without CAD (n = 6). The results were replicated in an extended sample of FH men (n = 61) and in non-FH men (n = 100) for two of the top differentially methylated loci.

Results: FH men with CAD had significantly more hypomethylated and hypermethylated loci and showed less DNA methylation level variability compared with men without CAD (p < 0.001). Moreover, COL14A1 and MMP9 DNA methylation levels were associated with CAD, age of onset of CAD or CAD risk factors.

Conclusion: These results suggest that epigenome-wide changes are associated with CAD occurrence in men.

Keywords: DNA methylation; arterial remodeling; candidate genes; cardiovascular diseases; epigenome-wide association study; gene expression; missing heritability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Collagen / genetics
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / genetics*
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Epigenomics / methods
  • Gene Ontology
  • Genome-Wide Association Study
  • Glycoproteins / genetics
  • Humans
  • Hyperlipoproteinemia Type II / complications*
  • Hyperlipoproteinemia Type II / genetics
  • Male
  • Matrix Metalloproteinase 9 / genetics
  • Middle Aged

Substances

  • COL14A1 protein, human
  • Glycoproteins
  • Collagen
  • MMP9 protein, human
  • Matrix Metalloproteinase 9